GH vs LLY · rev $739.0M vs P/E 39, rev $65.18B
Guardant Health Inc (GH) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Guardant Health Inc (GH) is a diagnostics & research company listed on US.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported GH revenue for 2024-12-31 was $739.0M. Net income was -$436.4M. Revenue was up 31.0% from 2023-12-31 to 2024-12-31. GH currently screens at market cap $6.32B.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
GH currently screens at market cap $6.32B. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the GH and LLY stock pages for the full models.
Not investment advice.